v3.26.1
OPERATING LEASE RIGHT-OF-USE ASSETS AND LEASE OBLIGATIONS
12 Months Ended
Mar. 31, 2026
Operating Lease Right-of-use Assets And Lease Obligations  
OPERATING LEASE RIGHT-OF-USE ASSETS AND LEASE OBLIGATIONS

12. OPERATING LEASE RIGHT-OF-USE ASSETS AND LEASE OBLIGATIONS

 

The Company has one operating lease primarily for office and administration.

 

During December 2021, the Company entered into a new lease agreement. The Company paid $85,000 deposit that would be returned at the end of the lease. In December 2022, the Company started a new lease with an additional suite in the same premise as the existing lease.

 

When measuring the lease obligations, the Company discounted lease payments using its incremental borrowing rate. The weighted-average-rate applied is 11.4%.

 

   2026   2025 
Right of Use Asset  $   $ 
Beginning balance at March 31   812,053    1,221,593 
New leases   -    - 
Amortization   (465,839)   (409,540)
Ending balance at March 31   346,214    812,053 

 

   2026   2025 
Lease Liability  $   $ 
Beginning balance at March 31   929,116    1,386,486 
New leases   -    - 
Repayment and interest accretion   (531,286)   (457,370)
Ending balance at March 31   397,830    929,116 
           
Current portion of operating lease liability   397,830    531,286 
Noncurrent portion of operating lease liability       397,830 

 

The operating lease expense was $627,728 for the year ended March 31, 2026 (2025: $587,045) and included in the selling, general and administrative expenses. Operating cash flows from operating leases amounted to $604,779 and $587,164 during the years ended March 31, 2026 and March 31, 2025, respectively.

 

 

BIOTRICITY INC.

Notes to Consolidated Financial Statements

Years ended March 31, 2026 and 2025

(Expressed in US Dollars)

 

The following table represents the contractual undiscounted cash flows for lease obligations as at March 31, 2026:

 

Calendar year  $ 
2026  411,170 
2027 and beyond   - 
      
      
Total undiscounted lease liability   411,170 
Less imputed interest   13,340 
Total   397,830